Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Management
Designation
No Data
Revenue and Profits:
Net Sales:
29 Million
(Quarterly Results - Mar 2026)
Net Profit:
21 Million
Pharmaceuticals & Biotechnology
ILS 1,011 Million ()
34.00
NA
2.97%
-0.16
2.40%
0.82






